Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique

Sponsor
Vienna Institute for Research in Ocular Surgery (Other)
Overall Status
Completed
CT.gov ID
NCT04883697
Collaborator
(none)
71
1
3.9
18

Study Details

Study Description

Brief Summary

A retrospective review of medical charts of patients having undergone vitrectomy with ILM Peeling and ILM flap technique for macular hole repair.

Condition or Disease Intervention/Treatment Phase
  • Other: vitrectomy with ILM peeling and ILM flap technique

Detailed Description

A retrospective review of medical charts of patients having undergone vitrectomy with ILM Peeling and ILM flap technique for macular hole repair. Pre- and postoperative OCT and visual acuity in the time period up to 6 months after surgery are reviewed and possible risk factors for failed macular hole closure or lower visual acuity outcome after surgery are assessed.

Study Design

Study Type:
Observational
Actual Enrollment :
71 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
May 1, 2021
Actual Study Completion Date :
May 1, 2021

Outcome Measures

Primary Outcome Measures

  1. visual acuity [change between visual acuity 2-6 months postoperative to baseline]

    best corrected distance visual acuity

  2. macular hole closure [2-6 months postoperative]

    closure of the macular hole assesed with OCT

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 105 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Vitrectomy with ILM peeling and ILM flap technique in the time period form 1.1.2015 to 31.4.2020

  • Age 18 or older

Exclusion Criteria:
  • Age <18

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vienna Institute for Research in Ocular Surgery Vienna Austria 1140

Sponsors and Collaborators

  • Vienna Institute for Research in Ocular Surgery

Investigators

  • Principal Investigator: Oliver Findl, Vienna Institute for Research in Ocular Surgery

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prim. Prof. Dr. Oliver Findl, MBA, Prim., Prof., MBA, Vienna Institute for Research in Ocular Surgery
ClinicalTrials.gov Identifier:
NCT04883697
Other Study ID Numbers:
  • RAI
First Posted:
May 12, 2021
Last Update Posted:
May 12, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 12, 2021